Literature DB >> 20434894

Effector and memory CD8+ T cell differentiation: toward a molecular understanding of fate determination.

Gabrielle T Belz1, Axel Kallies.   

Abstract

CD8(+) T cells play a key role in protecting the body against invading microorganisms. Their capacity to control infection relies on the development of peripheral effector and memory T cells. Much of our current knowledge has been gained by tracking alterations of the phenotype of CD8(+) T cells but the molecular understanding of the events that underpin the emergence of heterogeneous effector and memory CD8(+) T cells in response to infection has remained limited. This review focuses on the recent progress in our understanding of the molecular wiring of this differentiation process. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434894     DOI: 10.1016/j.coi.2010.03.008

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  24 in total

1.  Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination.

Authors:  Chiara Nembrini; Armando Stano; Karen Y Dane; Marie Ballester; André J van der Vlies; Benjamin J Marsland; Melody A Swartz; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

Review 2.  Nature and nurture: T-cell receptor-dependent and T-cell receptor-independent differentiation cues in the selection of the memory T-cell pool.

Authors:  Chulwoo Kim; Matthew A Williams
Journal:  Immunology       Date:  2010-08-25       Impact factor: 7.397

3.  Evaluation of non-reciprocal heterologous immunity between unrelated viruses.

Authors:  Jenny W Che; Liisa K Selin; Raymond M Welsh
Journal:  Virology       Date:  2015-03-31       Impact factor: 3.616

4.  Interleukin-21 Induces Short-Lived Effector CD8+ T Cells but Does Not Inhibit Their Exhaustion after Mycobacterium bovis BCG Infection in Mice.

Authors:  Naoto Noguchi; Risa Nakamura; Shinya Hatano; Hisakata Yamada; Xun Sun; Naoya Ohara; Yasunobu Yoshikai
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

5.  CD8 T cells recruited early in mouse polyomavirus infection undergo exhaustion.

Authors:  Jarad J Wilson; Christopher D Pack; Eugene Lin; Elizabeth L Frost; Joshua A Albrecht; Annette Hadley; Amelia R Hofstetter; Satvir S Tevethia; Todd D Schell; Aron E Lukacher
Journal:  J Immunol       Date:  2012-03-23       Impact factor: 5.422

6.  The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells.

Authors:  Kevin Man; Maria Miasari; Wei Shi; Annie Xin; Darren C Henstridge; Simon Preston; Marc Pellegrini; Gabrielle T Belz; Gordon K Smyth; Mark A Febbraio; Stephen L Nutt; Axel Kallies
Journal:  Nat Immunol       Date:  2013-09-22       Impact factor: 25.606

7.  A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet.

Authors:  Annie Xin; Frederick Masson; Yang Liao; Simon Preston; Tianxia Guan; Renee Gloury; Moshe Olshansky; Jian-Xin Lin; Peng Li; Terence P Speed; Gordon K Smyth; Matthias Ernst; Warren J Leonard; Marc Pellegrini; Susan M Kaech; Stephen L Nutt; Wei Shi; Gabrielle T Belz; Axel Kallies
Journal:  Nat Immunol       Date:  2016-03-07       Impact factor: 25.606

8.  Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma.

Authors:  Stephen R Goding; Kyle A Wilson; Ying Xie; Kristina M Harris; Aparna Baxi; Akgul Akpinarli; Amy Fulton; Koji Tamada; Scott E Strome; Paul Andrew Antony
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

9.  Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory.

Authors:  Youn Soo Choi; Jessica A Yang; Isharat Yusuf; Robert J Johnston; Jason Greenbaum; Bjoern Peters; Shane Crotty
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

10.  Decreases in activated CD8+ T cells in patients with severe hepatitis B are related to outcomes.

Authors:  Yinong Ye; Jing Liu; Qing Lai; Qiyi Zhao; Liang Peng; Chan Xie; Genglin Zhang; Shaoquan Zhang; Yufeng Zhang; Jianyun Zhu; Yangsu Huang; Zhaoxia Hu; Dongying Xie; Bingliang Lin; Zhiliang Gao
Journal:  Dig Dis Sci       Date:  2014-08-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.